Immunology in medical practice. XXII. T-cells and strategies for tolerance induction;Immunologie in de medische praktijk. XXII. T-cellen en tolerantiestrategieen

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 22, 1999, Pages 1148-1153

  Weenink, J J ^a   Wijburg, F A ^a   Bosman, D K ^a   Heymans, H S A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN RECOGNITION; CLINICAL PRACTICE; DESENSITIZATION; DRUG INDUCED DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ALLERGY AND IMMUNOLOGY; ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOSUPPRESSION; MALE; MICE; THYMUS GLAND;

EID: 0033614708     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Berge RJM ten, Melief CJM. De Nohelprijs Geneeskunde 1996 voor de ontdekking van 'MHC-restrictie'. Ned Tijdschr Geneeskd 1996; 140:2607-10.
2. Anderson G, Moore NC, Owen JJT, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol 1996;14:73-99.
3. Spits H. Early stages in human and mouse T-cell development. Curr Opin Immunol 1994;6:212-21.
4. Farr AG, Rudensky A, Medullary thymic epithelium: a mosaic of epithelial 'self'? J Exp Med 1998;188:1-4.
5. Kruisbeek AM, Amsen D. Mechanisms underlying T-cell tolerance. Curr Opin Immunol 1996;8:233-44.
6. Sykes M. Immunobiology of transplantation. FASEB J 1996;10:721-30.
7. Klatter FA, Raue HP, Bartels HL, Pater JM, Groen H, Nieuwenhuis P, et al. Simultaneous transplantation and intrathymic tolerance induction. A method with clinical potential. Transplantation 1995; 60:1208-10.
8. Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, et al. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation 1998;66: 1059-66.
9. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12: 809-37.
10. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998;187:2037-44.
11. Fisher GHY, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
12. Berden JHM. Immunologie in de medische praktijk. III. Lupus erythematodes disscminatus: gestoorde apoptose? Ned Tijdschr Geneeskd 1997;141:1848-54.
13. Parijs L van, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998;280:243-8.
14. Critchfield JM, Racke MK, Zuniga-Pflücker JC, Cannella B, Raine CS, Goverman J. el al. T cel deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994;263:1139-43.
15. Bertolino P, Heath WR, Hardy CL, Morahan G, Miller JFAP. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol 1995;25:1932-42.
16. Starzl TE. Zinkernagel RM. Mechanisms of disease: antigen localization and migration in immunity and tolerance. N Engl J Med 1998;339:1905-13.
17. Mueller DL, Jenkins MK. Molecular mechanisms underlying functional T-cell unresponsive-ness. Curr Opin Immunol 1995;7:375-81.
18. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R. Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381:434-8.
19. Liblau RS, Singer MS, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
20. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998;18:1-30.
21. Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998;28:1251-61.
22. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993;259:1321-4.
23. Deventer SJH van. Immunologie in de medische praktijk. IV. Inflammatoire darmziekten: pathogenetische aanknopingspunten voor specifieke therapie. Ned Tijdschr Geneeskd 1997;141:1956-9.
24. Romagnani P, Annunziato F, Baccari MC, Parronchi P. T cells and cytokines in Crohn's disease. Curr Opin Immunol 1997;9:793-9.